why choose us

First received: October 18, 2024

Clinical Trial: A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acne Vulgaris

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE-DOSE TOPICAL ADMIN

Brief Summary: The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07905428) for the potential treatment of acne vulgaris.This study is seeking participants who:Are male or female between the ages of 18 and 40Are generally healthyAre diagnosed with moderate to severe acne vulgaris (Cohort 4 only)The study medicine will be applied every day on the participant's face and/or back for 14 days (Cohorts 1 and 2) or for 28 days (Cohort 3 and 4).The investigators will…

Read more